(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TUBB4B mRNA] CTD PMID:31150632 (-)-demecolcine decreases expression ISO RGD:1601774 6480464 Demecolcine results in decreased expression of TUBB4B mRNA CTD PMID:23649840 (S)-colchicine decreases expression EXP 6480464 Colchicine results in decreased expression of TUBB4B mRNA CTD PMID:20624997 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of TUBB4B mRNA CTD PMID:30723492 17alpha-ethynylestradiol increases expression ISO RGD:1557719 6480464 Ethinyl Estradiol results in increased expression of TUBB4B mRNA CTD PMID:19400957 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of TUBB4B mRNA CTD PMID:19400957 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of TUBB4B mRNA CTD PMID:17351261 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1557719 6480464 2 more ... CTD PMID:30294300 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1557719 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1601774 6480464 Tetrachlorodibenzodioxin results in increased expression of TUBB4B mRNA CTD PMID:21807756 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TUBB4B mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of TUBB4B mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1557719 6480464 Tetrachlorodibenzodioxin affects the expression of TUBB4B mRNA CTD PMID:18343893 more ... 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:1557719 6480464 2 more ... CTD PMID:18343893 , PMID:20702594 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of TUBB4B mRNA CTD PMID:22584684 2-acetamidofluorene increases expression ISO RGD:1557719 6480464 2-Acetylaminofluorene results in increased expression of TUBB4B mRNA CTD PMID:21607683 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1557719 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of TUBB2C mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine affects methylation ISO RGD:1557719 6480464 N-Methyl-3, 4-methylenedioxyamphetamine affects the methylation of TUBB2C promoter CTD PMID:26251327 3-methylcholanthrene increases expression ISO RGD:1557719 6480464 Methylcholanthrene results in increased expression of TUBB4B mRNA CTD PMID:20713471 4-hydroxyphenyl retinamide decreases expression ISO RGD:1557719 6480464 Fenretinide results in decreased expression of TUBB4B mRNA CTD PMID:28973697 5-fluorouracil affects response to substance ISO RGD:1601774 6480464 TUBB4B protein affects the susceptibility to Fluorouracil CTD PMID:15548681 7,12-dimethyltetraphene multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 acetamide increases expression EXP 6480464 acetamide results in increased expression of TUBB4B mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO RGD:1557719 6480464 Aflatoxin B1 results in increased expression of TUBB4B mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1601774 6480464 Aflatoxin B1 results in decreased methylation of TUBB4B polyA tail CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1601774 6480464 Tretinoin results in decreased expression of TUBB4B mRNA CTD PMID:33167477 arsane decreases expression ISO RGD:1601774 6480464 Arsenic results in decreased expression of TUBB4B protein CTD PMID:19818359 arsenic atom decreases expression ISO RGD:1601774 6480464 Arsenic results in decreased expression of TUBB4B protein CTD PMID:19818359 arsenite(3-) multiple interactions ISO RGD:1601774 6480464 arsenite promotes the reaction [G3BP1 protein binds to TUBB4B protein] CTD PMID:32406909 azathioprine decreases expression ISO RGD:1601774 6480464 Azathioprine results in decreased expression of TUBB4B mRNA CTD PMID:22623647 beauvericin multiple interactions ISO RGD:1601774 6480464 [beauvericin co-treated with enniatins] results in increased expression of TUBB4B protein CTD PMID:32407736 benzo[a]pyrene increases expression ISO RGD:1557719 6480464 Benzo(a)pyrene results in increased expression of TUBB4B mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:1601774 6480464 Benzo(a)pyrene results in increased expression of TUBB4B mRNA CTD PMID:20498004 , PMID:31255691 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1601774 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:1557719 6480464 benzo(b)fluoranthene results in increased expression of TUBB4B mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of TUBB4B mRNA CTD PMID:20920545 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TUBB4B protein CTD PMID:22649256 bisphenol A affects expression ISO RGD:1601774 6480464 bisphenol A affects the expression of TUBB4B mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1601774 6480464 bisphenol A results in decreased expression of TUBB4B mRNA CTD PMID:29275510 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of TUBB4B protein CTD PMID:25933445 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of TUBB4B mRNA CTD PMID:12628495 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of TUBB4B mRNA CTD PMID:24136188 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of TUBB4B promoter CTD PMID:22457795 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of TUBB4B mRNA CTD PMID:25993096 carbamazepine affects expression ISO RGD:1601774 6480464 Carbamazepine affects the expression of TUBB4B mRNA CTD PMID:24752500 carbon nanotube decreases expression ISO RGD:1557719 6480464 Nanotubes, Carbon analog results in decreased expression of TUBB4B mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO RGD:1601774 6480464 Nanotubes, Carbon results in decreased expression of TUBB4B mRNA CTD PMID:28673683 chloropicrin affects expression ISO RGD:1601774 6480464 chloropicrin affects the expression of TUBB4B mRNA CTD PMID:26352163 chloropicrin increases expression ISO RGD:1601774 6480464 chloropicrin results in increased expression of TUBB2C mRNA CTD PMID:28476498 cisplatin decreases expression ISO RGD:1601774 6480464 Cisplatin results in decreased expression of TUBB4B mRNA CTD PMID:27594783 clozapine multiple interactions ISO RGD:1601774 6480464 [Cuprizone co-treated with Clozapine] results in decreased expression of TUBB4B protein CTD PMID:34122009 copper(II) sulfate decreases expression ISO RGD:1601774 6480464 Copper Sulfate results in decreased expression of TUBB4B mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:1601774 6480464 Coumestrol results in increased expression of TUBB4B mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1601774 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBB4B mRNA CTD PMID:19167446 Cuprizon multiple interactions ISO RGD:1601774 6480464 [Cuprizone co-treated with Clozapine] results in decreased expression of TUBB4B protein, [Cuprizone co-treated with Haloperidol] results in decreased expression of TUBB4B protein CTD PMID:34122009 cyclosporin A decreases expression ISO RGD:1601774 6480464 Cyclosporine results in decreased expression of TUBB4B mRNA CTD PMID:25562108 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of TUBB4B mRNA CTD PMID:23914054 diazinon increases expression EXP 6480464 Diazinon results in increased expression of TUBB4B mRNA CTD PMID:29108742 dibenzo[a,l]pyrene increases expression ISO RGD:1601774 6480464 dibenzo(a, l)pyrene results in increased expression of TUBB4B mRNA CTD PMID:31255691 diclofenac affects expression ISO RGD:1601774 6480464 Diclofenac affects the expression of TUBB4B mRNA CTD PMID:24752500 dioxygen decreases expression ISO RGD:1601774 6480464 Oxygen deficiency results in decreased expression of TUBB4B mRNA CTD PMID:26516004 dopamine increases expression EXP 6480464 Dopamine results in increased expression of TUBB4B mRNA CTD PMID:21983523 doxorubicin increases expression ISO RGD:1601774 6480464 Doxorubicin results in increased expression of TUBB4B mRNA CTD PMID:29803840 enniatin multiple interactions ISO RGD:1601774 6480464 [beauvericin co-treated with enniatins] results in increased expression of TUBB4B protein CTD PMID:32407736 Enterolactone multiple interactions ISO RGD:1601774 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBB4B mRNA CTD PMID:19167446 enzyme inhibitor multiple interactions ISO RGD:1601774 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TUBB4B protein CTD PMID:23301498 ethanol affects expression ISO RGD:1557719 6480464 Ethanol affects the expression of TUBB4B mRNA CTD PMID:30319688 fenoldopam increases expression EXP 6480464 Fenoldopam results in increased expression of TUBB4B mRNA CTD PMID:21983523 fenvalerate decreases expression EXP 6480464 fenvalerate results in decreased expression of TUBB4B protein CTD PMID:33656234 finasteride increases expression EXP 6480464 Finasteride results in increased expression of TUBB4B mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of TUBB4B mRNA CTD PMID:24136188 furan increases expression ISO RGD:1557719 6480464 furan results in increased expression of TUBB4B mRNA CTD PMID:24183702 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of TUBB4B mRNA CTD PMID:33387578 haloperidol multiple interactions ISO RGD:1601774 6480464 [Cuprizone co-treated with Haloperidol] results in decreased expression of TUBB4B protein CTD PMID:34122009 isoflavones multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 ivermectin decreases expression ISO RGD:1601774 6480464 Ivermectin results in decreased expression of TUBB4B protein CTD PMID:32959892 lead(II) chloride increases expression ISO RGD:1601774 6480464 lead chloride results in increased expression of TUBB4B protein CTD PMID:24419708 leflunomide decreases expression ISO RGD:1601774 6480464 leflunomide results in decreased expression of TUBB4B mRNA CTD PMID:28988120 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of TUBB4B mRNA CTD PMID:24136188 Licochalcone B increases expression ISO RGD:1601774 6480464 licochalcone B results in increased expression of TUBB4B mRNA CTD PMID:33647349 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of TUBB4B protein CTD PMID:19826936 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of TUBB4B mRNA CTD PMID:30467583 microcystin decreases expression EXP 6480464 Microcystins results in decreased expression of TUBB4B protein CTD PMID:22430071 N-(6-acetamidohexyl)acetamide increases expression ISO RGD:1601774 6480464 hexamethylene bisacetamide results in increased expression of TUBB4B protein CTD PMID:17569113 N-ethyl-N-nitrosourea increases expression ISO RGD:1557719 6480464 Ethylnitrosourea results in increased expression of TUBB4B mRNA CTD PMID:19100860 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of TUBB4B mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of TUBB2C mRNA CTD PMID:28943392 N-nitrosodiethylamine increases expression ISO RGD:1557719 6480464 Diethylnitrosamine results in increased expression of TUBB4B mRNA CTD PMID:19100860 more ... oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TUBB4B mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1557719 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TUBB4B mRNA CTD PMID:34911549 palbociclib decreases expression ISO RGD:1601774 6480464 palbociclib results in decreased expression of TUBB4B mRNA CTD PMID:22869556 paracetamol increases expression ISO RGD:1601774 6480464 Acetaminophen results in increased expression of TUBB4B mRNA CTD PMID:22230336 , PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of TUBB4B mRNA CTD PMID:33387578 paracetamol affects expression ISO RGD:1557719 6480464 Acetaminophen affects the expression of TUBB4B mRNA CTD PMID:17562736 pentachlorophenol increases expression ISO RGD:1557719 6480464 Pentachlorophenol results in increased expression of TUBB4B mRNA CTD PMID:23892564 perfluorononanoic acid decreases expression ISO RGD:1601774 6480464 perfluoro-n-nonanoic acid results in decreased expression of TUBB4B mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of TUBB4B mRNA CTD PMID:19162173 permethrin increases expression ISO RGD:1557719 6480464 Permethrin results in increased expression of TUBB2C mRNA CTD PMID:30629241 phenethyl isothiocyanate affects binding ISO RGD:1601774 6480464 TUBB4B protein binds to phenethyl isothiocyanate CTD PMID:21838287 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of TUBB4B mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:1557719 6480464 Phenobarbital affects the expression of TUBB4B mRNA CTD PMID:23091169 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of TUBB4B mRNA CTD PMID:22484513 pirinixic acid increases expression ISO RGD:1557719 6480464 pirinixic acid results in increased expression of TUBB4B mRNA CTD PMID:18301758 , PMID:20813756 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of TUBB4B mRNA CTD PMID:19162173 , PMID:22484513 propiconazole increases expression ISO RGD:1557719 6480464 propiconazole results in increased expression of TUBB4B mRNA CTD PMID:21278054 resorcinol increases expression ISO RGD:1601774 6480464 resorcinol results in increased expression of TUBB4B mRNA CTD PMID:22623647 resveratrol increases expression ISO RGD:1557719 6480464 resveratrol results in increased expression of TUBB4B protein CTD PMID:25505154 rotenone affects expression ISO RGD:1557719 6480464 Rotenone affects the expression of TUBB4B mRNA CTD PMID:21893155 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of TUBB4B protein CTD PMID:35544339 rotenone decreases expression ISO RGD:1601774 6480464 Rotenone results in decreased expression of TUBB4B mRNA CTD PMID:29955902 rotenone affects expression EXP 6480464 Rotenone affects the expression of TUBB4B mRNA CTD PMID:28374803 rotenone multiple interactions ISO RGD:1557719 6480464 TRP53 affects the reaction [Rotenone affects the expression of TUBB4B mRNA] CTD PMID:21893155 silicon dioxide increases expression ISO RGD:1601774 6480464 Silicon Dioxide analog results in increased expression of TUBB2C mRNA, Silicon Dioxide results in increased expression of TUBB2C mRNA CTD PMID:25351596 , PMID:25895662 silicon dioxide affects secretion ISO RGD:1601774 6480464 Silicon Dioxide analog affects the secretion of TUBB4B protein CTD PMID:25895662 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of TUBB4B mRNA CTD PMID:19072884 sodium arsenite increases expression ISO RGD:1557719 6480464 sodium arsenite results in increased expression of TUBB4B protein CTD PMID:29044176 sodium arsenite increases expression ISO RGD:1601774 6480464 sodium arsenite results in increased expression of TUBB4B mRNA CTD PMID:28595984 , PMID:34032870 sodium fluoride increases expression ISO RGD:1557719 6480464 Sodium Fluoride results in increased expression of TUBB4B protein CTD PMID:27548804 , PMID:28918527 sulforaphane affects binding ISO RGD:1601774 6480464 TUBB4B protein binds to sulforaphane CTD PMID:21838287 sulforaphane increases expression ISO RGD:1601774 6480464 sulforaphane results in increased expression of TUBB4B mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:1601774 6480464 Sunitinib results in decreased expression of TUBB4B mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1557719 6480464 Tamoxifen affects the expression of TUBB4B mRNA CTD PMID:20937368 tamoxifen increases expression ISO RGD:1557719 6480464 Tamoxifen results in increased expression of TUBB4B mRNA CTD PMID:19400957 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of TUBB4B mRNA CTD PMID:19400957 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TUBB4B mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of TUBB4B mRNA CTD PMID:31150632 thapsigargin decreases expression ISO RGD:1601774 6480464 Thapsigargin results in decreased expression of TUBB4B mRNA CTD PMID:22378314 thimerosal decreases expression ISO RGD:1601774 6480464 Thimerosal results in decreased expression of TUBB4B mRNA CTD PMID:27188386 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of TUBB2C mRNA CTD PMID:28943392 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of TUBB4B mRNA CTD PMID:34492290 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of TUBB4B mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TUBB4B mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of TUBB4B mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO RGD:1557719 6480464 trimellitic anhydride results in increased expression of TUBB4B mRNA CTD PMID:19042947 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of TUBB4B mRNA CTD PMID:30589522 trovafloxacin multiple interactions ISO RGD:1557719 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of TUBB4B mRNA CTD PMID:18930950 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of TUBB4B mRNA CTD PMID:24136188 tungsten increases expression ISO RGD:1557719 6480464 Tungsten results in increased expression of TUBB4B mRNA CTD PMID:30912803 tunicamycin decreases expression ISO RGD:1601774 6480464 Tunicamycin results in decreased expression of TUBB4B mRNA CTD PMID:22378314 , PMID:29453283 urethane increases expression ISO RGD:1601774 6480464 Urethane results in increased expression of TUBB4B mRNA CTD PMID:28818685 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of TUBB4B mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:1601774 6480464 Valproic Acid affects the expression of TUBB4B mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1601774 6480464 Valproic Acid results in increased expression of TUBB4B mRNA CTD PMID:28001369 valproic acid decreases expression ISO RGD:1601774 6480464 Valproic Acid results in decreased expression of TUBB4B mRNA CTD PMID:29154799 vincaleukoblastine decreases expression EXP 6480464 Vinblastine results in decreased expression of TUBB4B mRNA CTD PMID:20624997 vincristine decreases expression ISO RGD:1601774 6480464 Vincristine results in decreased expression of TUBB4B mRNA CTD PMID:23649840 vincristine decreases expression EXP 6480464 Vincristine results in decreased expression of TUBB4B mRNA CTD PMID:20624997 vitamin E increases expression ISO RGD:1601774 6480464 Vitamin E results in increased expression of TUBB4B mRNA CTD PMID:19244175 zoledronic acid decreases expression ISO RGD:1601774 6480464 zoledronic acid results in decreased expression of TUBB4B mRNA CTD PMID:24714768